Biophytis S.A. (BPTSY)
USD 3.05
(0.0%)
USD 3.05
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 2.98 Million EUR | -20.68% |
| 2022 | 3.76 Million EUR | 151.95% |
| 2021 | -7.24 Million EUR | -164.42% |
| 2020 | 11.24 Million EUR | 31.37% |
| 2019 | 8.56 Million EUR | 410.28% |
| 2018 | -2.75 Million USD | 76.39% |
| 2017 | -11.68 Million USD | -460.54% |
| 2016 | -2.08 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 Q2 | 7.68 Million EUR | 0.0% |
| 2023 FY | 2.98 Million EUR | -20.68% |
| 2023 Q4 | 2.98 Million EUR | 0.0% |
| 2022 Q2 | -854.13 Thousand USD | 0.0% |
| 2022 Q4 | 3.76 Million EUR | 0.0% |
| 2021 Q2 | -5.71 Million USD | 0.0% |
| 2021 Q4 | -5.98 Million USD | 0.0% |
| 2020 Q4 | 7.03 Million USD | 0.0% |
| 2020 Q2 | 1.55 Million USD | 0.0% |
| 2019 Q4 | 8.56 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | 15.76 Million USD | 81.058% |
| Nanobac Pharmaceuticals, Incorporated | 4.11 Million USD | 27.493% |
| SQZ Biotechnologies Company | -36.23 Million USD | 108.24% |
| Evofem Biosciences, Inc. | 42.79 Million USD | 93.023% |
| Santhera Pharmaceuticals Holding AG | -6.3 Million USD | 147.361% |
| Mesoblast Limited | 55.85 Million USD | 94.655% |
| Propanc Biopharma, Inc. | 927.18 Thousand USD | -222.036% |
| Genus plc | 190.6 Million USD | 98.433% |
| VioQuest Pharmaceuticals, Inc. | 2.23 Million USD | -33.546% |
| CNBX Pharmaceuticals Inc. | 1.21 Million USD | -145.976% |
| Marizyme, Inc. | 18.56 Million USD | 83.92% |
| ContraFect Corporation | -6.02 Million USD | 149.55% |
| Nymox Pharmaceutical Corporation | 680 Thousand USD | -339.098% |
| PsyBio Therapeutics Corp. | 134.63 Thousand USD | -2117.685% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.15 Million USD | -158.421% |
| Intellipharmaceutics International Inc. | 2.24 Million USD | -33.165% |
| AXIM Biotechnologies, Inc. | 5.5 Million USD | 45.73% |
| MultiCell Technologies, Inc. | 90.04 USD | -3316058.374% |
| Accustem Sciences Inc. | -733.97 Thousand USD | 506.806% |
| RVL Pharmaceuticals plc | 12.94 Million USD | 76.936% |
| EV Biologics, Inc. | 1.36 Million USD | -118.27% |
| Q BioMed Inc. | 4.06 Million USD | 26.457% |
| Emmaus Life Sciences, Inc. | 30.55 Million USD | 90.228% |
| Neon Bloom, Inc. | 622.36 Thousand USD | -379.762% |
| Mosaic ImmunoEngineering Inc. | 1 Million USD | -196.301% |
| Biomind Labs Inc. | 711.4 Thousand USD | -319.716% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 109.8 Million USD | 97.281% |
| Oncotelic Therapeutics, Inc. | 12.8 Million USD | 76.685% |
| Skye Bioscience, Inc. | -5.72 Million USD | 152.188% |
| Therapeutic Solutions International, Inc. | 860.24 Thousand USD | -247.097% |
| THC Farmaceuticals, Inc. | 139.8 Thousand USD | -2035.754% |
| Arch Therapeutics, Inc. | 5.64 Million USD | 47.138% |
| IMV Inc. | 7.67 Million USD | 61.073% |
| Acro Biomedical Co., Ltd. | 19.86 Thousand USD | -14929.29% |
| Curative Biotechnology, Inc. | 2.2 Million USD | -35.599% |
| GB Sciences, Inc. | 1.74 Million USD | -70.883% |
| Alpha Cognition Inc. | -183.78 Thousand USD | 1724.627% |
| HST Global, Inc. | 96.79 Thousand USD | -2984.798% |
| CSL Limited | 10.52 Billion USD | 99.972% |
| Halberd Corporation | 144.72 Thousand USD | -1963.19% |
| Enzolytics Inc. | 981.65 Thousand USD | -204.167% |
| Resverlogix Corp. | 6.45 Million USD | 53.715% |
| Affymax, Inc. | -5.59 Million USD | 153.348% |
| SYBLEU INC | 473.71 Thousand USD | -530.31% |
| Nuo Therapeutics, Inc. | -673.08 Thousand USD | 543.607% |
| argenx SE | -2.02 Billion USD | 100.147% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | 43.43 Million USD | 93.126% |
| Enzon Pharmaceuticals, Inc. | -47.01 Million USD | 106.351% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | 2.7 Million USD | -10.236% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | -8.83 Million USD | 133.777% |
| AVAX Technologies, Inc. | -5.9 Million USD | 150.58% |
| Zenith Capital Corp. | 10.06 Thousand USD | -29568.81% |
| Genscript Biotech Corporation | -1.06 Billion USD | 100.281% |
| Ember Therapeutics, Inc. | 200.43 Thousand USD | -1389.717% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 2.38 Million USD | -25.139% |
| WPD Pharmaceuticals Inc. | 164.5 Thousand USD | -1715.019% |
| American Oriental Bioengineering, Inc. | 60.54 Million USD | 95.068% |
| Provectus Biopharmaceuticals, Inc. | 1.99 Million USD | -49.339% |
| Adynxx, Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | -2.57 Million USD | 216.18% |
| GlobeStar Therapeutics Corporation | 359.71 Thousand USD | -730.077% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 20.27 Million USD | 85.274% |
| Cotinga Pharmaceuticals Inc. | -18.31 Thousand USD | 16400.191% |
| BioStem Technologies, Inc. | 4.47 Million USD | 33.232% |
| ONE Bio Corp. | 9.04 Million USD | 66.971% |
| Reve Technologies, Inc. | 201.25 Thousand USD | -1383.632% |
| Burzynski Research Institute, Inc. | -1310.00 USD | 228028.931% |
| Wesana Health Holdings Inc. | 206.21 Thousand USD | -1347.926% |
| Agentix Corp. | 37.63 Thousand USD | -7834.599% |
| LadRx Corporation | -2.03 Million USD | 246.62% |
| Cell Source, Inc. | 9.23 Million USD | 67.657% |
| ProtoKinetix, Incorporated | -20.4 Thousand USD | 14730.875% |
| Regen BioPharma, Inc. | 635.16 Thousand USD | -370.092% |
| Regen BioPharma, Inc. | 635.16 Thousand USD | -370.092% |
| NovAccess Global Inc. | 2.17 Million USD | -37.063% |
| Endonovo Therapeutics, Inc. | 7.07 Million USD | 57.773% |
| Itoco Inc. | 228.3 Thousand USD | -1207.842% |
| Rasna Therapeutics, Inc. | 135.98 Thousand USD | -2095.67% |
| Pathfinder Cell Therapy, Inc. | 4.95 Million USD | 39.765% |
| Kadimastem Ltd | -253.1 Thousand USD | 1279.71% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Institute of Biomedical Research Corp. | 401.84 Thousand USD | -643.033% |
| CytoDyn Inc. | 20.26 Million USD | 85.264% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | -647.00 USD | 461594.436% |
| Mobile Lads Corp. | 484.23 Thousand USD | -516.62% |
| NanoSphere Health Sciences Inc. | -9268.34 USD | 32315.791% |
| Qrons Inc. | 351.42 Thousand USD | -749.641% |
| Alseres Pharmaceuticals, Inc. | 7.7 Million USD | 61.253% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | -249.62 Thousand USD | 1296.166% |
| Rebus Holdings, Inc. | 305 Thousand USD | -878.973% |
| ImmunoCellular Therapeutics, Ltd. | 4.45 Million USD | 33.008% |
| International Stem Cell Corporation | 2.59 Million USD | -15.285% |
| Bioxytran, Inc. | 1.89 Million USD | -57.241% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 62.41 Thousand USD | -4684.05% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 2.18 Million USD | -36.91% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 3.43 Million USD | 13.05% |
| Adhera Therapeutics, Inc. | 8.55 Million USD | 65.09% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 772.6 Thousand USD | -286.467% |
| Innovation Pharmaceuticals Inc. | -1.25 Million USD | 338.87% |
| Neutra Corp. | 52.18 Thousand USD | -5621.48% |
| Windtree Therapeutics, Inc. | -2.48 Million USD | 219.963% |
| PureTech Health plc | -167.19 Million USD | 101.786% |
| Coeptis Therapeutics, Inc. | -244.9 Thousand USD | 1319.18% |
| IXICO plc | -4.44 Million USD | 167.18% |
| IntelGenx Technologies Corp. | 13.21 Million USD | 77.412% |
| Gelesis Holdings, Inc. | 54.85 Million USD | 94.556% |
| CSL Limited | 10.52 Billion USD | 99.972% |
| Cellectis S.A. | -43.81 Million USD | 106.814% |